tiprankstipranks
Advertisement
Advertisement

JP:4552 Stock Latest News

JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
Company AnnouncementsJCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
29d ago
4552
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
PremiumCompany Announcements
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
29d ago
4552
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
29d ago
4552
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
PremiumCompany Announcements
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
29d ago
4552
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
29d ago
4552
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
PremiumCompany AnnouncementsJCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
29d ago
4552
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
Premium
Company Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
29d ago
4552
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
Premium
Company Announcements
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
1M ago
4552
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
PremiumCompany Announcements
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
3M ago
4552
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
4M ago
4552
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
PremiumCompany Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
4M ago
4552
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
4M ago
4552
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
PremiumCompany AnnouncementsJCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
4M ago
4552
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
Premium
Company Announcements
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
5M ago
4552
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
Premium
Company Announcements
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
6M ago
4552
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
PremiumCompany Announcements
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
7M ago
4552
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
PremiumCompany Announcements
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
8M ago
4552
JCR Pharmaceuticals Advances in MPS IIIB Treatment with JR-446 Study
PremiumCompany Announcements
JCR Pharmaceuticals Advances in MPS IIIB Treatment with JR-446 Study
8M ago
4552
JCR Pharmaceuticals Reports Q1 FY2025 Financial Results with Positive Sales Growth
PremiumCompany Announcements
JCR Pharmaceuticals Reports Q1 FY2025 Financial Results with Positive Sales Growth
11M ago
4552
JCR Pharmaceuticals Completes Treasury Stock Disposition for Compensation
PremiumCompany AnnouncementsJCR Pharmaceuticals Completes Treasury Stock Disposition for Compensation
11M ago
4552
JCR Pharmaceuticals Announces Treasury Stock Disposition for Incentive Plan
Premium
Company Announcements
JCR Pharmaceuticals Announces Treasury Stock Disposition for Incentive Plan
12M ago
4552
JCR Pharmaceuticals Strengthens Ties with MEDIPAL HOLDINGS for Global Expansion
Premium
Company Announcements
JCR Pharmaceuticals Strengthens Ties with MEDIPAL HOLDINGS for Global Expansion
12M ago
4552

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >